DeCS Categories
D03 Heterocyclic Compounds .
D03.132 Alkaloids .
D03.132.960 Xanthines .
D03.132.960.751 Theophylline .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.759 Purines .
D03.633.100.759.758 Purinones .
D03.633.100.759.758.824 Xanthines .
D03.633.100.759.758.824.751 Theophylline .
E01 Diagnosis .
E01.370 Diagnostic Techniques and Procedures .
E01.370.600 Physical Examination .
E01.370.600.700 Range of Motion, Articular .
E02 Therapeutics .
E02.095 Biological Therapy .
E02.095.465 Immunomodulation .
E02.095.465.425 Immunotherapy .
E02.095.465.425.400 Immunization .
E02.095.465.425.400.330 Immunization, Passive .
E02.760 Patient Care .
E02.760.169 Continuity of Patient Care .
E02.760.169.063 Aftercare .
E02.760.169.063.500 Rehabilitation .
E02.760.169.063.500.387 Exercise Therapy .
E02.760.169.063.500.387.500 Motion Therapy, Continuous Passive .
E02.779 Physical Therapy Modalities .
E02.779.483 Exercise Therapy .
E02.779.483.500 Motion Therapy, Continuous Passive .
E02.779.867 Musculoskeletal Manipulations .
E02.779.867.761 Motion Therapy, Continuous Passive .
E02.831 Rehabilitation .
E02.831.535 Physical Therapy Modalities .
E02.831.535.483 Exercise Therapy .
E02.831.535.483.500 Motion Therapy, Continuous Passive .
E02.831.535.867 Musculoskeletal Manipulations .
E02.831.535.867.761 Motion Therapy, Continuous Passive .
E05 Investigative Techniques .
E05.478 Immunologic Techniques .
E05.478.550 Immunization .
E05.478.550.520 Immunization, Passive .
G11 Musculoskeletal and Neural Physiological Phenomena .
G11.427 Musculoskeletal Physiological Phenomena .
G11.427.760 Range of Motion, Articular .
Terms Synonyms & Historicals Documents LILACS e MDL
Motion Therapy, Continuous Passive . Continuous Passive Movement Therapy . Movement Therapy, Continuous Passive . Passive Movement Therapy, Continuous . CPM Therapies . Therapies, CPM . Therapy, CPM . Continuous Passive Motion Therapy . CPM Therapy . Passive Motion Therapy, Continuous . Movement of a body part initiated and maintained by a mechanical or electrical device to restore normal range of motion to joints, muscles, or tendons after surgery, prosthesis implantation, contracture flexion, or long immobilization. . 1.00
Theophylline . 1,3-Dimethylxanthine . 3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione . Accurbron . Aerobin . Aerolate . Afonilum Retard . Aquaphyllin . Armophylline . Bronchoparat . Bronkodyl . Constant-T . Elixophyllin . Euphylong . Glycine Theophyllinate . Lodrane . Monospan . Nuelin . Nuelin S.A. . Quibron T-SR . Slo-Phyllin . Somophyllin-T . Sustaire . Synophylate . Theo Von Ct . Theo-24 . Theo-Dur . Theobid . Theocin . Theoconfin Continuous . Theodur . Theolair . Theolix . Theon . Theonite . Theopek . Theophylline Anhydrous . Theophylline Sodium Glycinate . Theospan . Theostat . Theovent . Uniphyl . Uniphyllin . Uniphylline . 1,3 Dimethylxanthine . Anhydrous, Theophylline . Constant T . ConstantT . Ct, Theo Von . Glycinate, Theophylline Sodium . Quibron T SR . Quibron TSR . Slo Phyllin . SloPhyllin . Sodium Glycinate, Theophylline . Somophyllin T . SomophyllinT . Theo 24 . Theo Dur . Theo24 . Theophyllinate, Glycine . Von Ct, Theo . A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP. . 0.47
Immunization, Passive . Passive Immunotherapy . Therapy, Immunoglobulin . Antibody Transfer, Passive . Antibody Transfers, Passive . Immunizations, Passive . Immunoglobulin Therapies . Immunotherapies, Passive . Passive Antibody Transfers . Passive Immunization . Passive Immunizations . Passive Immunotherapies . Serotherapies . Therapies, Immunoglobulin . Transfer, Passive Antibody . Transfers, Passive Antibody . Immunotherapy, Passive . Passive Antibody Transfer . Passive Transfer of Immunity . Serotherapy . Immunoglobulin Therapy . Normal Serum Globulin Therapy . Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). . 0.45